A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

NCT07195916 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

280

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors
Hematologic Malignancies

Interventions

DRUG: INCA036873

Sponsor

Incyte Corporation